Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Dr Reddy's share price plummets 7% as Q3 fails to impress Street; Jefferies cuts target
Jefferies said that Dr Reddy's weakness in core profitability showed up in the Q3 numbers. The company also faced incremental competition in top products and higher selling expenses in the quarter.
Dr Reddy’s shares plummet 4.4% in the wake of logging modest Q3 growth
Dr Reddy’s Laboratories reports 2% increase in net profit, attributing growth to new acquisitions and product launches.
Indian drugmaker Dr Reddy's shares slide after Q3 profit miss
(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine months, after missing its third-quarter profit estimates on lower sales and pricing pressures in the key North American market.
Dr Reddy's Laboratories share price declines 6% post Q3 results: Should you Buy, Sell or Hold ?
Dr Reddy's Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday
Dr Reddy’s Q3 profit rises 2%
Hyderabad: Despite posting record revenues, pharma major Dr Reddy's Laboratories on Thursday reported a marginal 2% increase in consolidated profit after tax (PAT attributable to equity holders) at 1,
Indian drugmaker Dr Reddy's misses Q3 profit view on weak pricing in US
BENGALURU/HYDERABAD (Reuters) -Indian generic drugmaker Dr Reddy's Laboratories reported third-quarter profit below expectations on Thursday, hurt by pricing pressure in the competitive North American market,
Dr Reddy's Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16%
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars.
2h
Q3 Results 2025 LIVE: Indigo, DLF, JSW Steel among 81 companies set to announce Q3 results today
UltraTech Cement, Dr Reddy’s Labs, Hindustan Petroleum, Mphasis, Zee, Indus Towers, Adani Green Energy, Adani Energy ...
cnbctv18
49m
Q3 Results LIVE: Shriram Finance likely to report healthy loan growth in Dec quarter
Torrent Pharma, IndiGo parent InterGlobe Aviation, Godrej Consumer Products, JSW Steel, and Bank of India are among few of the key firms that will report Q3 results today. Track updates here ...
The Financial Express
1h
Q3 Results Live Updates: DLF, Interglobe Aviation, Godrej Consumer, NIIT, Bank of India, others releasing Q3 results today
Today, majors including DLF, Interglobe Aviation, Godrej Consumer Products, NIIT, DCB Bank, Bank of India, others are ...
25m
on MSN
Cyient Shares Nosedive 20% To Fresh 52 Week Low After PAT Declines 31.7% Sequentially In Dissapointing Q3 Earnings
Cyient Shares nosedived on NSE (National Stock Exchage) to new 52 week low level of Rs 1,404.15 after comapny declared their ...
1h
Shriram Finance shares trade flat ahead of Q3 results today, loan growth likely up 18% YoY
Shriram Finance is expected to post an 18 percent year-on-year (YoY) growth in loans for Q3FY25, with sequential growth ...
1h
This Tata Group stock slips 9%, gives up Rs 1,000 mark on Q3 earnings
The stock slumped 9 per cent to hit a low of Rs 994.05 over its previous close of Rs 1096.75. Market cap of the Tata Group ...
cnbctv18
1h
Indus Towers Q3 results boost hopes of a larger dividend payout from the company
Brokerage firm Citi maintained its "buy" rating on Indus Towers with a price target of ₹485, citing three key positives from ...
LIVE
8h
Ultratech Cement Q3 Results 2025 Highlights: Ultratech Cement share price ends over 6% higher after Q3 earnings
Ultratech Cement reported a 17% YoY decline in its net profit in the December quarter. Volume is was recorded at 10% YoY.
Hosted on MSN
1h
MakeMyTrip Stock Surges After Q3 Revenue Jump: Retail's Not Convinced
Shares of MakeMyTrip ($MMYT) jumped 6% on Thursday as the online travel company reported strong revenue jump for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Hindustan Unilever
HUL
HDFC Bank
Zomato
Donald Trump
Feedback